Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy.

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy.'. Together they form a unique fingerprint.

Medicine & Life Sciences